ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Shares Sold by Capital Investment Advisors LLC

Capital Investment Advisors LLC lowered its position in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBFree Report) by 5.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,996 shares of the exchange traded fund’s stock after selling 549 shares during the period. Capital Investment Advisors LLC’s holdings in ProShares Ultra Nasdaq Biotechnology were worth $506,000 at the end of the most recent quarter.

Separately, Jane Street Group LLC boosted its stake in ProShares Ultra Nasdaq Biotechnology by 8.4% in the third quarter. Jane Street Group LLC now owns 4,803 shares of the exchange traded fund’s stock valued at $306,000 after acquiring an additional 374 shares in the last quarter.

ProShares Ultra Nasdaq Biotechnology Stock Performance

NASDAQ BIB opened at $50.82 on Thursday. ProShares Ultra Nasdaq Biotechnology has a 1 year low of $47.19 and a 1 year high of $69.56. The company has a fifty day moving average of $55.73 and a two-hundred day moving average of $61.08.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The firm also recently announced a dividend, which was paid on Tuesday, December 31st. Stockholders of record on Monday, December 23rd were issued a $0.3964 dividend. This is a boost from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15. The ex-dividend date of this dividend was Monday, December 23rd.

About ProShares Ultra Nasdaq Biotechnology

(Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.

Further Reading

Want to see what other hedge funds are holding BIB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIBFree Report).

Institutional Ownership by Quarter for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.